Introduction {#S1}
============

Total hip replacement (THR) is one of the most successful and cost-effective of surgical procedures with the primary goals of pain relief and restoration of function. Since THRs were introduced, there has been steady improvement in the technology associated with it, leading to better functional outcome and implant survivorship.^[@R1]^ The success of THRs and the increasing frequency of its use is largely due to the development of the cemented low-friction arthroplasty with its high survival rate.^[@R2],[@R3]^ However, the outcomes of other cemented THR prostheses were poor with high and early loosening rate, primarily due to the implant designs and cementing techniques in many cases. The cement itself was considered a cause of loosening leading the term *cement disease.* The uncemented THR was developed to avoid these problems; however the early designs had similarly poor outcomes. The development of circumferentially coated uncemented implants which allow bone to grow into or onto the prosthesis has led to an improved implant survival rate and supported their growing use, despite higher costs.^[@R4]--[@R6]^ Published studies comparing cemented to uncemented THRs are rare. The majority of these are retrospective, non-randomised comparisons,^[@R7],[@R8]^ or comparison in the same patient with bilateral THRs.^[@R9],[@R10]^ Various randomized controlled trials (RCTs) have been designed to compare the clinical and radiological outcomes of cemented versus uncemented fixation.^[@R11],[@R12]^ Thus far no one study has been able to draw a decisive conclusion because of inherent limitations. Furthermore, there are no horizontal or longitudinal comparisons of the published RCTs in the literature. Our study aims to determine whether the contemporary hip surgeons should abandon the proven dependability of cemented fixation for the emerging technology of cementless fixation.

Objectives {#S2}
==========

This review aims to systematically evaluate all RCTs comparing cemented versus uncemented fixation of THRs, with no restriction to the patients age.

Information sources {#S3}
===================

A comprehensive search across multiple Databases was performed for studies published in English and other languages. Databases included Medline, BIOSYS, Embase, Web of Science, CAB Health, Cumulative Index to Nursing and Allied Health Literature, Science Citation Index/ Current Contents and the Cochrane Library (Issue 4, 2010). The reference list of each study was reviewed to find additional relevant studies. Experts in the field and manufacturers of implants were contacted to identify further studies. The so called grey literature was identified using the Inside Database of the British Library, the System for Information on Grey Literature in Europe, and relevant abstract bands. The studies not published because of negative results or other reasons were identified from online trial registers (UK National Research Register of ongoing health research, information on clinical trials sponsored by the NIH and The International Register of Clinical Trials Registers).

Eligibility criteria {#S4}
====================

Types of studies
----------------

We included reports of only RCTs. In the case of multiple publications of a trial, we included the first published article. Exceptions were made if a more recent publication corroborates the results of a longer follow up or examined a different outcome or both.

Types of participants
---------------------

Humans aged 18 years or older who underwent a primary THR were eligible.

Types of interventions and comparison
-------------------------------------

The intervention of interest is the implantation of primary cemented THRs compared to primary uncemented THRs.

Types of outcome measures
-------------------------

The primary outcome is failure of the primary procedure, measured objectively by the revision rate due to aseptic loosening of either the cup or the stem. Secondary outcomes included radiological signs of loosening or osteolysis, mortality, complications, pain score, functional scores mainly Harris Hip Score (HHS) and Merle-D\'Aubigne score, follow up duration and radiostereometric analysis (RSA).

Selection criteria
------------------

Inclusion criteria were established *a priori* to minimize selection bias. The objective was to identify all RCTs with comparison of cemented versus uncemented fixation of THRs. Studies that included arthroplasty for trauma, tumor cases, animal studies, studies containing previously published data or poorly randomized trials were excluded.

Data collection and analysis
----------------------------

Initial screening of articles was performed by primary author. Two reviewers then independently assessed each of the studies for eligibility for inclusion. Any disagreements were resolved by consensus.

Statistical analysis
--------------------

Meta-analyses were computed using Review Manager 5 from the Cochrane collaboration. The impact of sample size was addressed by estimating a weighting factor for each study, and assigning larger effect-weights in studies with bigger samples.

Effect sizes measured were relative risk (RR) for categorical variables and mean difference (MD) for continuous variables. Outcome variables that were reported in a comparable manner among at least three RCTs were included in meta-analyses. Pooled estimation of the RRs and MDs of each RCT and the corresponding 95% Confidence Intervals (CI) were calculated by the random effect model and heterogeneity was described by the I2 statistic. We predefined significant heterogeneity as I2\>50%.

An estimate of the potential publication bias was carried out by funnel plot. An asymmetric plot suggested a possible publication bias.

Subgroup analyses for primary outcomes (revision rate, pain and HHS scores) were performed analyzing separately the RCTs with less than 5 year follow up (short term follow-up) and those with more than 5 years (long term follow-up). P value less than 0.05 was considered as statistically significant.

Reporting was carried out in line with PRISMA Statement (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines.^[@R13]^

Results {#S5}
=======

Study selection
---------------

Of the 107 citations identified through literature searches ([Figure 1](#F1){ref-type="fig"}), 16 were assessed for eligibility.^[@R12],[@R14]--[@R28]^ Seven studies were excluded, five were reporting previously published data,^[@R14],[@R16],[@R18]--[@R20]^ one was not a proper RCT and one was RCT comparing cemented with another cemented implant.^[@R15],[@R17]^ Nine RCTs met all of our inclusion criteria.^[@R12],[@R21]--[@R28]^

Figure 1Flow chart of selection process.

A total of 930 THRs were performed in 778 patients in these studies: 330 patients were males and 448 were females; 459 had cemented and 471 had cementless prosthesis. The mean age was 60.5 years. The average post operative follow up was 4.3 (range 2--8) years ([Table 1](#T1){ref-type="table"}). Mortality and post-operative complications at their last follow up are shown in [Table 2](#T2){ref-type="table"} and [Table 3](#T3){ref-type="table"} respectively. Two RCTs compared cemented and uncemented sockets, 4 compared cemented and uncemented femoral stems while the rest compared both components. The implant types reported by these studies are listed in [Table 4](#T4){ref-type="table"}.

Table 1Patients characteristics of in both groups.Study IDMean age (years)Gender (male/female)Matched variables between cemented and uncemented groupsFollow up (years)P. McCombe 200467.376/86Age, follow-up, diagnosis6.5Laupacis 20026433/31Age, sex, follow-up, weight, diagnosis6.3S. P. GODSIFF 199264.529/29Age, follow-up, diagnosis2Håkan Ström 20065415/30Age, follow-up, weight, diagnosis8Reigstad 19936432/88Age, sex, follow-up, weight, diagnosis, right/left ratio, clinical and radiographic assessments of the arthrosis5Wykman *et al.* 199166.257/93Age, follow-up, weight5Onsten & Carlsson 199460.241/40Age, sex, follow-up, weight, diagnosis, right/left ratio2J Karrholm 19945331/30Age, sex, weight, the roentgenographic quality of the bone; and the reason for the operation2Grant 200551.616/21Age2

Table 2Post operative mortality.StudyCemented groupTotalCementless groupTotalP. McCombe 200419631652Laupacis 20021812417126S. P. GODSIFF 1992030028Håkan Ström 2006023022Reigstad 1993560460Wykman *et al.* 1991490490Onsten & Carlsson 1994430330J. Karrholm 1994NR20NR44Grant 2005019019Total5044[^3]

Table 3Summary of post operative complications.StudyComplicationsP. McCombe 2004 thought toFour acetabular prostheses were revised for recurrent dislocation; these were all Duraloc cups and the dislocations were have been caused by the prominent 10° lipLaupacis 2002NRS. P. GODSIFF 1992One patient in the cemented group suffered a postoperative pulmonary embolus and subsequent cardiac arrest. She was successfully resuscitated, made a full recovery, and went on to have an excellent result at two yearsHåkan Ström 2006NRReigstad 1993No serious operative or postoperative complications occurredWykman *et al.* 1991One patient was reoperated at 2 months with a Girdlestone hip because of infection. In the Charnley group 2 patients had their prostheses removed because of deep infectionOnsten & Carlsson 1994NRJ Karrholm 1994NRGrant 2005One patient had a superficial wound infection, and one a weak abductor function with a Trendelenburg gait[^4]

Table 4Implants characteristics.StudyLocationCompared componentsNon compared componentsCemented implantCementless implantP. McCombe 2004AustraliaPolyethylene Exeter cupDuraloc cupCemented double-taper stem (Exeter; Stryker Australia)Laupacis 2002CanadaMallory-Head total hip prosthesisMallory-Head total hip prosthesisHips with both cemented components were compared to hips with both uncemented componentsS. P. GODSIFF 1992UKRing UPM stemRing UPM stemThe acetabular components were all implanted without cementHåkan Ström 2006SwedenBimetric stemCone stemAll patients in the randomized study received a cemented Cenator (Corin, Cirencester, UK) acetabular componentReigstad 1993Norway(Landos Titane) total hip prosthesis(ZweymOller/Endler cup) total hip prosthesisHips with both cemented components were compared to hips with both uncemented componentsWykman *et al.* 1991SwedenCharnley total hip prosthesisHonart Patel-Garches (press fit)Hips with both cemented components were compared to hips with both uncemented componentsOnsten & Carlsson 1994SwedenCharnley socketHarris-Galante socketCharnley femoral component (head 22 mm) was cemented in all casesJ Karrholm 1994SwedenTifit straight-stem femonal prosthesis of the same basic design made of titaniumaluminum-vanadium alloy implant total hip prosthesisTifit straight-stem femonal prosthesis of the same basic design made of titaniumaluminum-vanadium alloy implant total hip prosthesisA press-fit acetabular cup with titanium-fiber mesh was inserted without cement and was additionally fixed with screws (Harris-Galante I or II; Zimmen, Warsaw, Indiana) in all of the hipsGrant 2005NorwayElite Plus stem implant total hip prosthesisCustom made Unique stem implant total hip prosthesisUncemented Duraloc (DePuy) acetabular component in all patients except one

Results of meta-analyses
------------------------

The revision rates were reported in 6 RCTs (719 patients). The cemented THRs had a higher but statistically non significant revision rate (RR=1.44; 95% CI, 0.88 to 2.35; P=0.14) with nonsignificant heterogeneity (I2=3%) for this outcome ([Table 5](#T5){ref-type="table"}, [Figure 2](#F2){ref-type="fig"}). Subgroup analysis ([Figure 3](#F3){ref-type="fig"}) showed no change in results for RCTs reporting a follow up greater than 5 years (RR=1.43; 95% CI, 0.70 to 2.93; P=0.32). Visual inspection of the funnel plot showed asymmetry ([Figure 4](#F4){ref-type="fig"}).

Table 5Pooled relative risk (RR) and mean difference (MD).OutcomeRCTsMeta-analysesHeterogeneity I^[@R2]^NPatientsRRMD95% CIPOverall revision67191.440.88; 2.350.143%Short term follow up of revision2220NCNCNCNCLong term follow up of revision45951.430.70; 2.930.3227%Overall pain score76951.130.03; 2.230.0493%Short term follow-up for pain42201.800.09; 3.510.0492%Long term follow-up for pain34750.28−1.02; 1.580.6793%Overall HHS77571.12−1.17; 3.410.3499%Short term follow-up for HHS3162−0.50−2.65; 1.650.6592%Long term follow-up for HHS45952.31−0.74; 5.360.1499%Radiological osteolysis57100.540.19; 1.570.2685%Mortality57251.060.73; 1.520.770%Complications43911.540.21; 11.030.6742%[^5]

Figure 2Forest plot of comparison: overall revision.

Figure 3Forest plot of comparison: long term follow-up (\>5 years) for revision.

Figure 4Funnel plot of comparison: overall revision.

Pain scores were reported in 7 RCTs (695 patients). Four RCTs with short term and three with long follow-up evaluated this outcome ([Figures 5](#F5){ref-type="fig"} and [6](#F6){ref-type="fig"}). Meta-analysis of all RCTs ([Figure 7](#F7){ref-type="fig"}, [Table 5](#T5){ref-type="table"}) revealed significantly improved pain score with cemented fixation (MD=1.13; CI: 0.03--2.23; P=0.04) compared with uncemented fixation. Similar results ([Figure 5](#F5){ref-type="fig"}) were obtained for RCTs with short term follow-up (MD=1.80; CI: 0.09-3.51; P=0.04). The effect size was opposite for RCTs with long term follow-up ([Figure 6](#F6){ref-type="fig"}) but not statistically significant (MD=0.28; CI: −1.02 to 1.58; P=0.67). Statistically significant heterogeneity (I2\>90%) and symmetric funnel plots were noted ([Figure 8](#F8){ref-type="fig"}).

Figure 5Forest plot of comparison: short term follow-up (\<5 years) for pain score.

Figure 6Forest plot of comparison: long term follow-up (\>5 years) for pain score.

Figure 7Forest plot of comparison: overall pain score outcome.

Figure 8Funnel plot of comparison: hhort term follow-up (\<5 years) for pain dcore.

Statistically significant higher average HHS scores were reported in 4 of 7 RCTs in the uncemented group however pooled estimations of the average HHS score MDs did not show statistically significant difference ([Table 5](#T5){ref-type="table"}, [Figure 9](#F9){ref-type="fig"}).

Figure 9Pooled mean difference for pain score and functional outcome score measured by HHS.

The Relative risk (RR) of outcomes for mortality, complications, and radiological osteolysis were similar between the two groups ([Table 5](#T5){ref-type="table"}, [Figure 10](#F10){ref-type="fig"}).

Figure 10Pooled Relative Risk for all outcomes.

Summary of evidence
-------------------

A meta-analysis is a useful tool as the results of cemented and uncemented components can be compared together as a package. There were several different components used in these selected studies, the influence of these variables (implant shape, material, etc) could be evaluated with a meta-analysis. Only 9 RCTs met our inclusion criteria. Our study did not demonstrate an overall superiority of either fixation method as measured by implant survival. Comparison of the studies with relatively short follow up versus studies with longer follow up without restriction to the patient\'s age demonstrated statistically significant differences, in particular better pain scores in the cemented groups. The difference in pain decreases with longer follow up though the cemented implant group still reported better pain scores overall.

Definitions of failure in hip replacement
-----------------------------------------

A careful approach must be taken when analyzing each study for their definitions of success and failure. Criteria for failure can include revision rates, radiographic observations (demarcation, migration and cement fracture), and clinical failure (pain, reduced function and limited motion). Wejkner and Stenport showed that if only revision surgery was considered failure, their failure rate was 4% but taking other parameters into consideration the rate of clinical failure was 8%.^[@R29]^ Radiographic failure generally occurs first, followed by clinical failure with pain, loss of function, and finally, revision surgery. The lowest rate of failure will generally be the reoperation rate. Definition of failure in implant survival studies is fraught with inconsistencies. While we attempted to use estimates based on revisions undertaken for any reason, as this is less subjective than *aseptic loosening* or *mechanical failure,* the propensity for differential misclassification and resulting bias is present. This is because the decision to undertake a revision is influenced by the opinions of the surgeon and the patient.

Moreover, revisions are occasionally performed on well-fixed implants without evidence of infection or mechanical failure, and many radiographically loose or symptomatic implants are not revised.

Cemented versus uncemented fixation
-----------------------------------

Under the broad category of cement disease, investigators include a variety of deleterious processes that occur in conjunction with mechanical loosening of cemented implants. Despite the absence of a precise pathophysiology, it is apparent that a pernicious granulomatous response to cement and polyethylene particles, leading to the erosion of bone.^[@R30]^ It may occur in the presence or absence of loosening.^[@R31]^ The advantage of biologic fixation is very clear as every major survivorship analysis of cemented fixation demonstrates a progressive time dependent loss of fixation.^[@R32],[@R33]^ It has been implied that once stable fixation occurs in the cementless implant, it does not deteriorate with time.^[@R34]^ Further independent, unbiased studies are required to validate this. Cementless femoral components are more expensive than uncemented components.^[@R35]^

Another potential advantage in uncemented fixation is that bone loss will not occur despite loosening, in contrast to the dramatic osteolysis seen in loose cemented implants. However there is evidence to contradict this, with bone loss demonstrated in loose uncemented implants.^[@R36]^ A much lower rate of thromboembolism has been shown in uncemented THRs in one study.^[@R37]^ This observation requires further studies to validate it.

Roder *et al.*^[@R38]^ found in their study of 4420 matched case controlled THAs that women had a significantly reduce odds ratio of acetabular component failure compared to men and was lower still for women with cemented compared to those with uncemented acetabular component. The study also found that obesity a significant risk factor for failure of the acetabular component with the uncemented cups having a higher odds ratio. Furthermore they found that in patients with dysplastic hips there was a significant decrease in the risk of failure in the cemented group.

In a recent literature review Clement *et al.*^[@R39]^ concluded that cemented fixation remains gold standard for the acetabulum as the overall and all cause reoperation risk was lower for cemented fixation. Pavkis *et al.* showed no difference e in the complications, wear, osteolysis, migration and clinical scores when they looked at only RCTs in their systematic review of literature. Non RCT studies revealed better osteolysis, migration properties and aseptic loosening survival for uncemented acetabular components. However in terms of wear and overall survival favored the cemented acetabular components.^[@R40]^ In a RCT involving 240 THRs Bjørgul *et al.*^[@R41]^ found that at 10-years follow up that there was no clinical and radiological difference between the cemented Charnley cup and the uncemented Duraloc cup. All had received a cemented Charnley stem. There was similarly no difference in the implant survival at 12--14 yeas follow up. A more recent RCT involving 250 patients with a minimum 17 year follow-up showed lower survival rates of cemented compared with cementless THA with Kaplan-Meier survivorship analysis at 20 years.^[@R42]^ Age less than 65years and male gender were significantly predictive for risk of revision surgery.

In a direct comparison study of 92 patients Bjerkholt *et al.*^[@R43]^ found that there was higher wear in those that had an uncemented acetabular component at 9--10 years follow-up, however the difference was not significant. Patients over 70 yrs of age received a cemented acetabular component and those under 60 years of age received an uncemented acetabular component.

Clinical and functional evaluation {#S6}
==================================

Cemented femoral component provides an immediate postoperative advantage in terms of better integration between bone, cement and the prosthesis, which permits dramatic early relief of pain and early weight-bearing. In the short term outcome, our study shows almost all the relevant studies reported superiority of the cemented fixation to the uncemented in terms of pain reduction. Therefore, we conclude that for the clinical and functional outcome, the cemented group tends to be equal, if not superior, to the uncemented group.

Radiological evaluation {#S7}
=======================

A poor correlation between radiographic and clinical findings with intraoperative findings during revision surgery has demonstrated in either component.^[@R44],[@R45]^ Our finding supports that most radiographic differences were variable and did not seem to correlate with clinical findings.

Osteolysis is the leading concern for surgeons performing THRs and its incidence is influenced by many factors such as cementing techniques and prosthesis type. Only 4 studies examined RSA and in general there was no difference in migration or rotation of the compared implants.^[@R22],[@R23],[@R25],[@R27]^ There was no correlation between weight, age or sex. These observations cannot be generalized and are limited to the few implants compared.

Role of randomized controlled trials and registry data {#S8}
======================================================

This review illustrates the advantages and limitations of RCT in assessing the effectiveness of new orthopedic devices. The RCT is considered the gold standard for the design of clinical research however, there are several drawbacks with this study design, such as the risk of performance bias between centers of excellence and routine surgery,^[@R46]^ RCTs are expensive, labor intensive and has a late feedback because of the demand for long-term follow-up.^[@R47]^ The performance of a RCT might be of limited value if the prosthesis used may have been redesigned during or soon after the study is completed and this adds to the cost, logistical difficulty, and potentially rendering the study irrelevant.^[@R8],[@R12]^ Another disadvantage of many RCTs is that strict inclusion and exclusion criteria lead to a highly selected group of patients who are operated on by a small number of surgeons. This makes the generalizability of the results to *the real world* uncertain. Among the RCTs in our review, a sample size calculation was conducted in only one study.^[@R12]^ A total of 300 subjects were needed to ensure the statistical significance. However, due to slower-than-expected recruitment rate, the recruitment was stopped when 250 patients had been randomized. Insignificant differences are likely to result from the smaller sample size. Due to the obvious disadvantages of performing randomized studies, there is debate as to whether RCTs can be replaced by observational studies such as register studies which can document long-term performance and safety of the prosthesis in *the real world.* RCTs will, however, continue to be valuable. Garellick *et al.*^[@R48]^ compared the long-term survival results of two different hip implants with the results from the Swedish National Hip Registry. They concluded that despite the enormous amount of data, the registries can never replace a prospective, randomized trial.

Currently the data from the several national arthroplasty registries ([Tables 6](#T6){ref-type="table"}--[8](#T8){ref-type="table"}) show that cemented implants have a favorable outcome when revision of the implants is taken as the endpoint. The Norwegian registry data shows survivorship of cemented implants to be better but not significantly different.^[@R49]^ When Malchau *et al.*^[@R50]^ looked at the Swedish arthroplasty register and Lutch looked at the Danish arthroplasty register their findings suggested that cemented implants had a similar lower revision rate.^[@R51]^ However the uncemented implants did better in the less than 55 age group in both registers.

Table 6Demographic of registry studies.StudyCountryAge (years)GenderTHR (number)CementedCementlessHybridHailer *et al.* 2010Sweden60-7556.532 M170.413161.4608953N/A88.805 FWeiss *et al.* 2011Sweden72 (SD 11)987 M18858121073N/A898 FMäkelä *et al.* 2010Finland\>55N/A10.310954930.112N/ABordini *et al.* 2007Italy\<40 (408)1799 M4750(12.1%)(51.5%)(36.4%)40-69 (2965)2951 F\>70 (1377)NJR 2011UK72.8 (cemented)32.843 F71.67225.78931.30712.79465.4 (cementless)21.647 MHooper *et al.* 2009New Zealand\<55 (6430)N/A42.66516.00510.89815.18955-64 (10467)65-74 (13973)Reverse hybrid 573\>75 (11222)[^6]

Table 7Implants characteristics for registry studies.StudyCemented implantCementless implantHailer *et al.* 2010Five most common cups\
(Lubinus, Charnley, Exeter Duration, Charnley Elite, and Reflection);\
Five most common stems (Lubinus SP2, Exeter polished, Charnley, Spectron EF Primary, and Scan Hip Collar)Five most common cups (Trilogy HA, CLS Spotorno, Trilogy, Trident HA, and Allofit);\
Five most common stems (CLS, Bi-Metric HA, ABG, Omnifit, and Wagner Cone)Weiss *et al.* 2011Three most common (Lubinus, Exeter, and Spectron).MP hip reconstruction prosthesis (Waldemar Link, Germany)Makela *et al.* 2010Exeter Universal stem combined with the All-poly cup (Stryker, Mahwah, NJ);\
Müller Straight stem combined with the Müller Standard cup (Zimmer, Warsaw, IN);\
Lubinus SP II stem combined with the Lubinus IP cup (Waldemer Link, Hamburg, Germany)Anatomic Mesh/HG-II\
PCA Std/PCA Pegged\
Bi-Metric/PFU\
Bi-Metric/Mallory\
Bi-Metric/Vision\
ABG I/ABG I\
ABG I/ABG II\
ABG II/ABG IIBordini *et al.* 2007Cemented all polyethylene\
Contemporary howmedica\
(Mahwah, New Jersey, USA)\
Muller Cremascoli (Milano, Italy),\
Muller Sulzer (Geneve,Switzerland),\
Exeter Howmedica,\
STEMS\
LC Samo\
AHS Cremascoli\
Definition Howmedica\
Exeter Howmedica\
Gemini De Puy\
self-locking Sulzer\
Elite De Puy\
Lubinus SP 2 Link\
Press fit, ceramic or metal liner\
AnCA Fit Cremascoli,\
Duofit PSF Samo,\
Fitek Sulzer,\
Standard Cup Protek\
Press fit, polyethylene liner\
Duraloc De Puy (Warsaw, Indiana, USA)\
Fitek Sulzer,\
Duofit PSF Samo (Bologna, Italy),\
ABG Howmedica,\
Vitalock Talon Howmedica,\
PCA Howmedica,\
STEMS\
Cone prosthesis Sulzer,\
Meridian Howmedica,\
CLS Sulzer,\
Metabloc Sulzer,\
Anca Cremascoli\
Duofit RKT Samo\
PCA Howmedica\
Citation Howmedica\
AML Depuy stems\
Anca Fit Cremascoli\
Dual fit Cremascoli stems\
NJR 2011STEMS\
Exeter V40\
CPT\
C-Stem AMT Cemented Stem\
C-Stem Cemented Stem\
Charnley Cemented Stem\
CUPS\
Contemporary\
Elite Plus Ogee\
Elite Plus Cemented Cup\
Marathon\
Exeter Rimt\
STEMS\
Corail\
Furlong HAC Stem\
Accolade\
Taperloc Cementless Stem\
Versys Cementless Stem\
CUPS\
Pinnacle\
Trident\
Trilogy\
Exceed ABT\
CSF PlusCooper *et al.* 2009N/AN/A[^7]

Table 8Summary of registry study\'s findings.StudyOutcomeHailer *et al.* 2010Uncemented THA had a higher risk of revision for any reason.\
Uncemented cup had a higher risk of cup revision due to aseptic loosening.\
Uncemented stem had a lower risk of stem revision due to aseptic loosening.\
No significant difference in the risk of revision due to infection between cemented and uncemented THA.Weiss *et al.* 2011Survival was better for the cemented stems with up to 3 years of follow-up.\
Decreasing age, multiple previous revisions, short stem length, standard neck offset and short head-neck length were risk factors for reoperation.Mäkelä *et al.* 2010Cementless stem had a higher survival rate at 15 years in patients aged \>55 years.\
Polyethylene wear and osteolysis remain a serious problem for cementless cup designs with unplugged screw holes and low-quality liners.Bordini *et al.* 2007Cemented cups and stems have a higher risk of failure compared with uncemented ones.\
Worst survival of the prosthesis are associated with male patients, younger than 40 years, affected by sequelae of congenital diseases, operated by a surgeon who performed less than 400 total hip artroplasty.NJR 2011Revision rate for uncemented THRs is twice that of the cemented THRs at five years.\
The rate for hybrid THRs tends to lie between the rates for cemented and uncemented THRs.Hooper *et al.* 2009Fully-cemented THRs had a lower rate of revision while uncemented THRs had a lower rate \<65 years.\
The rate of revision of the acetabular component was less in the uncemented and hybrid groups.\
The rate of revision of cemented and uncemented femoral components was similar, except in patients \>75 years of age in whom revision of cemented femoral components was significantly less frequent.\
Revision for infection was more common in patients aged \<65 years and in cemented and hybrid THRs.\
Dislocation was the most common cause of revision for all types of fixation and was more frequent in both uncemented acetabular groups.\
The experience of the surgeon did not affect the findings.

Hailer *et al.*^[@R52]^ looked at data from the Swedish registry involving over a 170,413 THAs. Uncemented THAs (85%) had a significantly lower 10 year survival rate compared to the cemented THA (94%). This was largely due to the poorer performance of the uncemented acetabular components. While uncemented stems had a lower revision rate due to loosening they had a higher revision rate due to periprosthetic fracture in the first two postoperative years. Weiss *et al.*^[@R53]^ on the other hand reviewed the Survival of uncemented acetabular monoblock cups which represent a subtype of uncemented cups with the polyethylene liner molded into the metal shell and compared their survival to the modular designs in 210 hips from the Swedish Hip Arthroplasty Register. They concluded that both cups showed good survival rates at 11 years of follow up.

The data from the Finnish arthroplasty registry regarding THAs in the under 55-year age group showed higher revision rates for aseptic loosening in the cemented group compared to the proximally coated uncemented femoral components. The cemented all-polyethelyne acetabular components had a revision rate three times as high as the porous coated uncemented acetabular components. However there was no difference between cemented and uncemented implants when the end point was revision for any cause.^[@R54]^ The Finnish arthroplasty registry data regarding the 55-year and older age group suggests that there is no significant difference in overall implant survival between the two groups. Uncemented porous coated femoral components survived better in the 55-year to 74-year age group while in the 75-year and older age group there was no significant difference.^[@R55]^

The New Zealand registry show similar results. THAs with cemented acetabular and femoral components had a higher survival rate when all revision for all causes is taken into consideration. Uncemented THAs had a lower revision rate in the less than 65 years age group. Revision for aseptic loosening of the acetabular component was considerably lower in the uncemented and hybrid THA group with the exception of those aged over 75 years where the cemented acetabular components did better.^[@R56]^ Data from the Rizolli Institute registry in Italy shows that uncemented implants generally outperformed the cemented implants. They suggest that as experience with uncemented implants is increasing the results are improving, particularly in the younger THA patient. Interestingly they noted that the more expensive the prosthesis, the longer it survived.^[@R57]^ The 2011 National Joint registry data for England and Wales shows that the revision rate at five years for uncemented THRs is twice that of the cemented THRs.^[@R58]^ The rate for hybrid THRs tends to lie between the rates for cemented and uncemented THRs. These registry data suggest that cemented implants seem to have an overall better survival rates.

A met-analysis of previously published studies up to 2005 by Morshed *et al.*^[@R59]^ found that there was no difference in failure when defined as revision of one or both components of a THR. They found superior survival rates for cemented fixation for all age groups. Cemented titanium stems and threaded acetabular components had a poor survival rate. They noted a difference in the implant survival and the year of publication of studies with uncemented implant survival improving with time. While overall revision rates were higher in uncemented acetabular components in a study by Hartofilakidis *et al.*,^[@R60]^ they found that revision rates for aseptic loosening for the cemented acetabular component (28%) was more than twice that of uncemented components (12%). However they noted aggressive expansile osteolysis with the uncemented acetabular components, thought to be due to a combination of polyethylene and metal wear debris from the uncemented metal backed components.

The revision rate for infection is overall similar between the uncemented THA and the cemented THA with antibiotic cement. Revision rate was due to infection was 1.8 times higher in the cemented THAs where antibiotic cement was not used.^[@R61]^

Bias and confounders {#S9}
====================

While all included studies were randomized the potential for bias and confounders were not absent. Of the 9 RCTs, only one study documented proper randomization techniques, concealment of allocation, and discussed reasons for exclusion or non-participation.^[@R12]^

Losses to follow-up or non-response during data collection are sources of selection bias and were not addressed in most RCTs in this review. Of the 3 RCTs that mentioned the reasons for their exclusion and censoring, only one study accounted for withdrawals that the CONSORT statement requires.^[@R12],[@R62]^

Review limitations {#S10}
==================

Several limitations in our work are important to note. In any systematic review or meta-analysis, there may be publication bias, incomplete ascertainment of studies and errors in data extraction. By restricting our analysis to RCTs, all factors that might affect outcomes are similarly distributed between the groups. We attempted to minimize errors in data extraction through cross-checking of all quantitative information by two authors. We used all available sources of data identified from a comprehensive literature search, without language restriction. Given the limitations in the published literature on this topic, the methods used in this study had limited bias and explored sources of heterogeneity to the greatest degree possible.

Conclusions {#S11}
===========

Although there are some limitations in the selected studies, our review showed no significant difference between cemented and cementless group in terms of implant survival as measured by the revision rate, mortality or the complication rate. Radiographic differences were variable and do not seem to correlate with clinical findings. It is almost certain that better shortterm clinical outcomes mainly improved pain score can be obtained from cemented fixation; this is still unclear for the long-term clinical and functional outcome. We strongly emphasize the need for more uniform standards in the selection of control groups in future trials.
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